Previous 10 | Next 10 |
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced the appointment of Dr. Jeffrey Vacirca to its ...
BYSI's lead candidate plinabulin in combo with Neulasta reduces grade 4 neutropenia in chemo patients better than Neulasta alone. However, the company is in perpetual cash-hungry mode, and every time it raises cash, the stock suffers. Catalysts are about a year ahead, but dilution...
- The plinabulin + pegfilgrastim combination reduces the incidence of profound neutropenia (ANC < 0.1 x 10E9 cells/L) by 53 % vs. pegfilgrastim alone - The plinabulin + pegfilgrastim combination reduces the odds of having febrile neutropenia by 41% vs. pegfilg...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 10:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. The major stock market averages all closed up more than 2% for the holiday-shortened week, as an early recovery-play rally gave way to a tech-safety trade...
B eyondSpring to present at the 62nd American Society of Hematology (ASH) Annual Meeting and at the 2020 San Antonio Breast Cancer Symposium NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) -- BeyondSpring (the “Company” or “...
NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies to transform the lives of patients with unmet medi...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks ended lower on Friday on raised concerns over the economic impact of the pandemic and the Treasury Department's new curtailing of emergency economic...
X Financial (XYF) -33%.MeiraGTx Holdings (MGTX) -10% on public offering pricing at $12.85/share.Tantech Holdings (TANH) -9%.BeyondSpring (BYSI) -9% on public offering pricing at $10.0/share.Chindata Group Holdings (CD) -7% on Q3 earnings release.Phoenix Tree Hold...
BeyondSpring (BYSI) slips 9% premarket, after pricing its previously announced public offering of 7.5M shares at $10.0/share, for gross proceeds of ~$75M.The offering is expected to close by November 23. For further details see: BeyondSpring slides 9% on public offering pricing at $10.0...
BeyondSpring (BYSI) -3.5% AH, launched an underwritten public offering of $75M; underwriters granted an option to purchase up to an additional $11.25M shares.Proceeds to be used for supporting the commercialization of Plinabulin, continued clinical and pre-clinical development and for ge...
News, Short Squeeze, Breakout and More Instantly...
COPT Defense Properties of Beneficial Interest (CDP) is expected to report $0.64 for Q2 2024 Bank of Marin Bancorp (BMRC) is expected to report $0.19 for Q2 2024 Oak Ridge Financial Services Inc (BKOR) is expected to report for Q2 2024 D/B/A Centerspace (CSR) is expected to report $1....
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...
FLORHAM PARK, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it hosted a virtua...